HeartSciences Inc. financial data

Symbol
HSCS, HSCSW on Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
550 Reserve St, Suite 360, Southlake, TX
State of incorporation
TX
Fiscal year end
April 30
Former names
Heart Test Laboratories, Inc. (to 10/18/2024)
Latest financial report
10-Q - Q3 2024 - Dec 16, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 343 % +237%
Quick Ratio 32 % +9.4%
Debt-to-equity 40 %
Return On Equity -118 % -111%
Return On Assets -84.1 % +59.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 980K shares -98.5%
Common Stock, Shares, Outstanding 948K shares -91.5%
Entity Public Float 21.1M USD +17.9%
Common Stock, Value, Issued 948 USD -91.5%
Weighted Average Number of Shares Outstanding, Basic 917K shares +735%
Weighted Average Number of Shares Outstanding, Diluted 917K shares +735%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 14.7K USD +654%
Cost of Revenue 4.56K USD +500%
Research and Development Expense 3.98M USD +59.1%
Operating Income (Loss) -7.47M USD -28.5%
Nonoperating Income (Expense) -159K USD +43.6%
Net Income (Loss) Attributable to Parent -7.62M USD -25.2%
Earnings Per Share, Basic 5.24 USD/shares +85.7%
Earnings Per Share, Diluted 5.24 USD/shares +85.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.05M USD +3946%
Accounts Receivable, after Allowance for Credit Loss, Current 14.7K USD
Inventory, Net 653K USD -3.25%
Other Assets, Current 40.4K USD 0%
Assets, Current 5.69M USD +214%
Property, Plant and Equipment, Net 77.1K USD +44.6%
Operating Lease, Right-of-Use Asset 418K USD -16.8%
Assets 7.78M USD +228%
Accounts Payable, Current 277K USD -74.6%
Accrued Liabilities, Current 370K USD -52.2%
Liabilities, Current 3.3M USD -6.47%
Operating Lease, Liability, Noncurrent 376K USD -22.7%
Liabilities 3.76M USD -6.41%
Retained Earnings (Accumulated Deficit) -71.5M USD -11.9%
Stockholders' Equity Attributable to Parent 4.02M USD
Liabilities and Equity 7.78M USD +228%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.02M USD -43.8%
Net Cash Provided by (Used in) Financing Activities 552K USD +70.1%
Net Cash Provided by (Used in) Investing Activities -833 USD +83%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 948K shares -91.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.47M USD -35.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.05M USD +3946%
Deferred Tax Assets, Valuation Allowance 14.1M USD +13.6%
Operating Lease, Liability 487K USD -16.2%
Depreciation 11.9K USD +61.7%
Payments to Acquire Property, Plant, and Equipment 4.91K USD -32.2%
Lessee, Operating Lease, Liability, to be Paid 603K USD -20.9%
Property, Plant and Equipment, Gross 601K USD +11.2%
Operating Lease, Liability, Current 111K USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 169K USD +2.49%
Lessee, Operating Lease, Liability, to be Paid, Year One 165K USD +2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 116K USD -35.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 174K USD +2.51%
Deferred Tax Assets, Operating Loss Carryforwards 10.4M USD -1.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 174K USD +2.51%
Operating Lease, Payments 13.1K USD 0%
Additional Paid in Capital 75.5M USD +21.4%
Interest Expense 354K USD +45.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%